Celecoxib Capsules — Class II drug recall D-0459-2025
Ongoing recall by Alembic Pharmaceuticals Limited, reported 2025-06-18, distributed nationwide. Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-co
| Recall number | D-0459-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Alembic Pharmaceuticals Limited, Panchmahal, India |
| Recall initiated | 2025-05-09 |
| Classified | 2025-06-06 |
| Reported by FDA | 2025-06-18 |
| Distributed | Nationwide (US) |
| NDC | 62332-0140, 62332-0140-08, 62332-0140-30, 62332-0140-60, 62332-0140-91, 62332-0141, 62332-0141-08, 62332-0141-30, 62332-0141-31, 62332-0141-60, 62332-0141-71, 62332-0141-91, 62332-0142, 62332-0142-08, 62332-0142-30, 62332-0142-31, 62332-0142-60, 62332-0142-71, 62332-0142-91, 62332-0143, 62332-0143-10, 62332-0143-30, 62332-0143-60, 62332-0143-71 |
| Lot numbers | 2405014780 |
| Expiration dates | 2027-09-30 |
Product
Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division), Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-142-71
Reason for recall
Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0459-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.